TMS is an FDA-approved treatment for major depressive disorder, obsessive-compulsive disorder and smoking cessation. TMS is covered by nearly every major insurance carrier for patients who have failed medication-based therapy and talk therapy. However, requirements for eligibility vary between insurance carriers.
TMS is very well-tolerated and allows the patient to engage in their daily activities without interruption. Mild headaches are the most common reported side effect associated with TMS. These are mild and generally diminish over the course of the treatment. Over-the-counter pain medication can be used to address them. The most common reported side effects of early stage TMS treatment are: ● Mild headache ● Scalp discomfort at the site of stimulation ● Tingling, spasms, or twitching of facial muscles ● Lightheadedness
Ketamine is used in hospitals and emergency settings daily to safely anesthetize patients, including pediatric surgery. The doses used for depression, anxiety, and PTSD treatments are sub-anesthetic so the incidence of complications is very limited. Additionally, you will be monitored by a trained medical professional at all times throughout the infusion to ensure a safe and tailored experience.
Yes, Tricare covers Transcranial Magnetic Stimulation (TMS) as an outpatient procedure. In 2016, Tricare, a health care plan issued by the United States Defense Health Agency (DHA), approved coverage for Outpatient TMS therapy for active duty or retired members of the armed forces. Spouses and children of serving or retired members of the military and members of the National Guard or Reserve are also eligible for Tricare TMS coverage if the beneficiary: ● Is 18 years of age or older ● Has severe Major Depressive Disorder (single or recurrent episodes) ● Has not responded positively to a less intensive form of treatment or that less intensive intervention is not more appropriate.
The most common side effects of Ketamine Infusion Therapy are nausea and dizziness. If you experience these symptoms during your infusion our clinical staff can administer antinausal medications to ease any discomfort, pause the treatment, and/or adjust the infusion rate to minimize the likelihood of side effects.
At this point intervenous ketamine infusion therapy has not been approved by the FDA and therefore is not covered by insurance companies. However, ketamine treatment for depression is slowly gaining adoption in the mainstream medical community and some commercial insurance carriers are beginning to cover treatment.
